Article in Medical Life Sciences News: Uniqsis FlowSyn continuous flow reactor helps simplify scale-up of API batch processes

Arcinova, a Quotient Sciences business, puchased a Uniqsis FlowSyn Continuous Flow Reator to support our drug substance capabilities. The addition of the Uniqsis FlowSyn™ reactor will enable Arcinova to develop and simplify the scale-up of a challenging API batch process. 

To access the full article visit:

We use cookies to help us to improve our site and enables us to the best possible service and customer experience. By clicking accept you are agreeing to let us share your data with select third parties for analytics and marketing purposes.